Variant report
Variant | esv3327506 |
---|---|
Chromosome Location | chr5:49940145-49943093 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188148651 | chr5:49940196-49940197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs35826255 | chr5:49940273-49940274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557354146 | chr5:49940279-49940280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369348411 | chr5:49940299-49940300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536442250 | chr5:49940305-49940306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114438013 | chr5:49940319-49940320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572566232 | chr5:49940320-49940321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544622565 | chr5:49940346-49940347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192708171 | chr5:49940452-49940453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147994768 | chr5:49940496-49940497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200467771 | chr5:49940516-49940517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183616735 | chr5:49940530-49940531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12653803 | chr5:49940561-49940562 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs529962716 | chr5:49940582-49940583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540388155 | chr5:49940599-49940600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559901708 | chr5:49940600-49940601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs528567572 | chr5:49940618-49940619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188327039 | chr5:49940621-49940622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571646708 | chr5:49940659-49940660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs72753742 | chr5:49940710-49940711 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs554896860 | chr5:49940758-49940759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs13159764 | chr5:49940840-49940841 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs567814357 | chr5:49940871-49940872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs199821817 | chr5:49940883-49940884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34139771 | chr5:49940884-49940885 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
26 | rs553119328 | chr5:49940895-49940896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566253941 | chr5:49940934-49940935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538377563 | chr5:49940947-49940948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs192426824 | chr5:49941000-49941001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185018047 | chr5:49941015-49941016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190178207 | chr5:49941019-49941020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181878818 | chr5:49941023-49941024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375328918 | chr5:49941024-49941025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184862350 | chr5:49941026-49941027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs189373847 | chr5:49941031-49941032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181227532 | chr5:49941050-49941051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368142208 | chr5:49941051-49941052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs372363197 | chr5:49941052-49941053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34336048 | chr5:49941057-49941058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs35117122 | chr5:49941059-49941060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs36086683 | chr5:49941061-49941062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184935937 | chr5:49941082-49941083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs376580426 | chr5:49941134-49941135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369838640 | chr5:49941135-49941136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189808940 | chr5:49941141-49941142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs372703648 | chr5:49941163-49941164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181819924 | chr5:49941164-49941165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375895248 | chr5:49941192-49941193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187364645 | chr5:49941201-49941202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368820322 | chr5:49941218-49941219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral cancer | 21386901 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:49933800-49942400 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
2 | chr5:49934200-49943800 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
3 | chr5:49939200-49942400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
4 | chr5:49939400-49942400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
5 | chr5:49939400-49942400 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
6 | chr5:49942400-49942600 | Enhancers | Primary T helper cells fromperipheralblood | blood |
7 | chr5:49942400-49943000 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
8 | chr5:49942400-49943600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
9 | chr5:49942400-49943600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr5:49942400-49944400 | Enhancers | Primary B cells from cord blood | blood |
11 | chr5:49942400-49946000 | Enhancers | Primary monocytes fromperipheralblood | blood |
12 | chr5:49942600-49944000 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
13 | chr5:49942600-49945000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr5:49943000-49943400 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
15 | chr5:49943000-49943800 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
16 | chr5:49943000-49944400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |